In the fast-moving world of biotechnology, where breakthroughs depend on both innovation and endurance, Leen Kawas believes that the most valuable resource isn’t capital or technology—it’s alignment. As CEO of EIT Pharma, managing general partner of Propel Bio Partners, and board member at Inherent Biosciences, Kawas has led teams through discovery, clinical development, and public markets. Across every stage, she has built organizations rooted in one principle: shared purpose drives sustainable progress.
Kawas’s philosophy on team-building was forged through experience. As co-founder and former CEO of Athira Pharma, she helped transform a scientific concept into a publicly traded company that raised over $400 million. The achievement, rare in itself, reflected more than strategic skill—it reflected her ability to unify scientists, investors, and executives around a single goal: improving patient outcomes. She learned that in biotech, alignment isn’t a soft skill—it’s a survival strategy.
For Kawas, building a mission-driven team begins with clarity. Every member, from the lab bench to the boardroom, must understand not just what the company does, but why. She encourages leaders to articulate purpose early and often, grounding even the most complex science in human impact. “When people connect emotionally to the mission,” she has said in various forums, “accountability becomes intrinsic.” That clarity transforms work from obligation to conviction—creating the resilience needed to navigate long development cycles and inevitable setbacks.
Recruiting for alignment, she notes, requires looking beyond résumés. Technical excellence is essential, but character and curiosity matter just as much. Leen Kawas seeks team members who demonstrate intellectual humility—the willingness to learn from failure and from each other. In high-stakes research environments, she values collaboration over competition. The best teams, she believes, balance deep expertise with shared empathy, ensuring that breakthroughs happen through integration rather than isolation.
Her leadership style reflects this philosophy. Kawas is known for fostering psychological safety while maintaining scientific rigor. She believes that innovation thrives where people feel empowered to question assumptions and propose unconventional ideas without fear of dismissal. In her organizations, mistakes are treated as data—information to refine, not grounds for reproach. That culture of openness builds trust, and trust, in turn, accelerates progress.
At Propel Bio Partners, the venture fund she co-founded, Kawas applies the same principles to the investment process. She partners with founders whose teams demonstrate cohesion and purpose, not just technical brilliance. Startups, she notes, often succeed or fail based on team dynamics rather than scientific potential. By investing in leadership alignment early, she helps companies avoid costly fragmentation later. “A great idea without a unified team,” she often remarks, “is a fragile business.”
Kawas also emphasizes diversity as a cornerstone of mission-driven teams. Her own career—one of only 22 women founders to take a biotech company public in the U.S.—has made her acutely aware of how representation shapes culture. She actively supports women and underrepresented voices in science and venture, believing that diverse teams make better decisions precisely because they bring different vantage points to the same shared mission. Diversity, for her, is not a metric—it’s a mechanism for discovery.
Beyond the lab, Kawas integrates empathy into organizational design. She encourages leaders to create environments that honor balance, mental health, and long-term sustainability. In biotechnology, where the work can span decades, burnout undermines both innovation and integrity. Her approach redefines productivity as consistency over intensity—sustaining motivation by keeping purpose visible and shared.
Ultimately, Leen Kawas views leadership as an act of translation: turning a collective mission into daily practice. Every meeting, milestone, and experiment must reflect the company’s core values. She believes that culture is not declared—it is demonstrated, through how decisions are made, how credit is shared, and how challenges are faced. Teams that internalize this alignment, she says, become self-reinforcing systems of trust and execution.
Through her ventures and leadership roles, Leen Kawas continues to model what it means to build teams that share a mission from the inside out. Her approach unites scientific excellence with emotional intelligence, creating organizations capable of both discovery and endurance. In her world, success is not just measured by clinical trials or market capitalization—it’s measured by cohesion, conviction, and the collective belief that science can serve humanity better when everyone pulling toward the goal truly believes in it.
Learn more about Leen Kawas in this in-depth interview with Billion Success.